Your search history is turned on.
Date: January 18, 2024 Jurisdictions: Ontario
Microsoft Word - Project Rambo - Application to Cease to be a Reporting Issuer (Passport)(48292176.2).docx McCarthy Ttrault LLP PO Box 48, Suite 5300 Toronto-Dominion Bank Tower Toronto ON M5K 1E6 Canada Tel: 416-362-1812 Haiya Peng Direct Line: (416) 601-8330 Email: [email protected] August 1, 2023 VIA SEDAR+ Ontario Securities Commission 20 Qu...
Microsoft Word - Project Rambo - Application to Cease to be a Reporting Issuer (Passport)(48292176.2).docx Schedule A Verification and Authorization Statement TO: Ontario Securities Commission, as Principal Regulator Reunion Neuroscience Inc. hereby authorizes the making and filing of the attached application by McCarthy Ttrault LLP, and confirms the acc...
Date: October 19, 2023 Jurisdictions: Ontario
Ontario Commission des 22nd Floor 22e tage Securities valeurs mobilires 20 Queen Street West 20, rue queen ouest Commission de lOntario Toronto ON M5H 3S8 Toronto ON M5H 3S8 August 11, 2023 In the Matter of the Securities Legislation of Ontario (the Jurisdiction) and In the Matter of the Process for Ce...
Date: August 1, 2023 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
Notice of Change in Corporate Structure Pursuant to Section 4.9 of National Instrument 51-102 Item 1 Names of the parties to the transaction Reunion Neuroscience Inc. (Reunion) 20231089 Parent, Inc. (formerly known as 20231089 Parent, LLC, the Parent) 15186111 Canada Inc. (formerly known as 1000548481 Ontario Inc., the Purchaser) Item 2 Description of the t...
Microsoft Word - Rambo - Press Release Announcing Closing (August 2023).DOCX FORM 51-102F3 MATERIAL CHANGE REPORT Item 1. Name and Address of Company Reunion Neuroscience Inc. ( Reunion) 30 Duncan Street, Lower North Suite Toronto, Ontario, M5V 2C3 Item 2. Date of Material Change August 1, 2023 Item 3. News Release Attached as Schedule A is a ...
A9wh12oa_1dcmmph_9c0.tmp 1DPHRIWKHDSSOLFDQWFRUSRUDWLRQV &RUSRUDWLRQQXPEHU 1DPHRIWKHRWKHUERGLHVFRUSRUDWHLQYROYHGLIDSSOLFDEOH &RUSRUDWLRQQXPEHURUMXULVGLFWLRQ 1DPHRIWKHFRUSRUDWLRQVWKHDUWLFOHVRIZKLFKDUHDPHQGHGLIDSSOLFDEOH &RUSRUDWLRQQXPEHU 1DPHRIWKHFRUSRUDWLRQVFUHDWHGE\DPDOJDPDWLRQLIDSSOLFDEOH &RUSRU...
Microsoft Word - Rambo - Press Release Announcing Closing (August 2023).DOCX Reunion Neuroscience Inc. and MPM BioImpact Announce Completion of Plan of Arrangement TORONTO, August 1, 2023 Reunion Neuroscience Inc. (TSX: REUN, NASDAQ: REUN) ("Reunion" or the "Company"), a clinical-stage biopharmaceutical company committed to developing innovative an...
Date: February 14, 2023 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
Reunion Neuroscience Provides Business Update and Reports Fiscal Third Quarter 2023 Financial Results Company Completed Phase 1 Interim Data Analysis for Lead Asset, RE104, Which Showed Strong Safety and Tolerability with Differentiated Profile; Final Data Anticipated in Mid-2023 Continued to Strengthen Executive Team; Named Dr. Robert Alexander as Chie...
Microsoft Word - REUN_CFO_Cert_Q3-2023 (002).DOCX 1 FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Edward Smith, Chief Financial Officer of Reunion Neuroscience Inc. (formerly Field Trip Health Ltd.), certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the "interim filings") of R...
Microsoft Word - REUN_CEO_Cert_Q3-2023 (003).DOCX 1 FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Gregory Mayes, Chief Executive Officer of Reunion Neuroscience Inc. (formerly Field Trip Health Ltd.), certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the "interim filings") of ...